<--- Back to Details
| First Page | Document Content | |
|---|---|---|
 Date: 2013-11-05 23:38:27Tübingen Matthias Hentze Friedrich Miescher Max Planck Society European Molecular Biology Laboratory Max Planck Institute for Infection Biology David Baulcombe University of Basel Max Planck Institute for Developmental Biology Science and technology in Germany Biology Research |
Add to Reading List |
EMBOEMBLSymp_NonCoding_2010_1.ai | Media release, October 23, 2014 Stopping anti-CCL2 breast cancer treatment aggravates the disease Mohamed Bentires-Alj and his team at the Friedrich Miescher Institute for Biomedical Research (FMI) together with scientiDocID: 1rf3r - View Document |
| Centre for Biomedical Genetics & Cancer Genomics Centre & CB G C G C November 10 & 11, 2011DocID: 1r5ek - View Document |
| PowerPoint-Präsentation - Folie 1DocID: 1oO6J - View Document |
| Institute Report 2011–2013 Max Planck Institute of Immunobiology and Epigenetics 2DocID: 1otNz - View Document |
| SFB 1064 Chromatin Dynamics Seminar Marc Bühler Friedrich-Miescher-InstitutDocID: 1oelf - View Document |